News

  • 16 August 2018

    NIH-funded study reverses congenital blindness in mice

    A new study funded by the National Institutes of Health (NIH) National Eye Institute (NEI) has successfully reversed congenital blindness by changing the supportive Müller glia cells in the retina...

  • 15 August 2018

    Mustang Bio licenses gene therapy for bubble boy disease

    US-based biopharmaceutical firm Mustang Bio has entered an exclusive worldwide licence agreement with St. Jude Children’s Research Hospital for a new gene therapy to treat X-linked severe combined immunodeficiency (X-SCID...

  • 15 August 2018

    Shire submits NDA in Japan for Intuniv to treat ADHD

    Irish biotechnology company Shire, through its partner Shionogi, has filed a new drug application (NDA) in Japan seeking approval to manufacture and market its Intuniv medicine for the treatment of...